SEC Form 5 · accession 0001264931-15-000087
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Noreen Griffin
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 17, 2015 · 12:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jun 16, 2014 | A | 0 | $0.00 | A | 2,685,000 | I | Through Noreen Griffin Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The total number of shares has been adjusted to reflect shares inadvertently not included in previous reports. These shares are held in an irrevocable trust for the benefit of the reporting person's children and grandchildren. The reporting person's sister-in-law is trustee of the trust.